Hostname: page-component-74d7c59bfc-6sd86 Total loading time: 0 Render date: 2026-02-09T14:27:39.775Z Has data issue: false hasContentIssue false

Bioactive ceramic-processed water modulates the gut microbiota and hepatic AMPK activation in SMP30 knockout mice

Published online by Cambridge University Press:  22 January 2026

Dong-Hun Kim
Affiliation:
Groundwater Environment Research Center, Geo-Environment Research Division, Korea Institute of Geoscience and Mineral Resources, Korea, Republic of
Soo-Nyun Choi
Affiliation:
Kyungpook National University College of Veterinary Medicine, Korea, Republic of
Kyongman An
Affiliation:
AI-Bio Convergence Research Institute, Department of Industrial AI Engineering, Hoseo University, Korea, Republic of
Ji-Hoon Kwak
Affiliation:
FM Animal Medical Center, Korea, Republic of
Kyung-Seok Ko
Affiliation:
Groundwater Environment Research Center, Geo-Environment Research Division, Korea Institute of Geoscience and Mineral Resources, Korea, Republic of
Kyu-Shik Jeong*
Affiliation:
Pet Industry, Daegu Haany University – Samseong Campus, Korea, Republic of Stellamed Co., Ltd., Korea, Republic of
*
Corresponding author: Kyu-Shik Jeong; Email: anistemcell@gmail.com

Abstract

Effects of BCP on Gut Microbiome and Liver Metabolism in SMP30 KO Mice. Abbreviations: BCP, Bioactive ceramic processed water; SMP30 KO, Senescence marker protein-30 knockout; AMPK, Adenosine monophosphate (AMP)-activated protein kinase; SCFA, Short chain fatty acids.

Effective strategies are needed to increase the healthy lifespan and prevent age-related diseases in aging populations. Using senescence marker protein 30 knockout (SMP30 KO) mice—models that mimic human vitamin C (vitC) deficiency and exhibit accelerated aging—we investigated the effects of bioactive ceramic processed water (BCP) compared to natural mineral water (MW) and MW supplemented with vitamin C (MW-vitC) on gut microbial communities and hepatic metabolism. Due to pooled fecal sampling (n=1 composite library per group), microbiome results represent descriptive trends in diversity and composition. BCP was associated with discernible shifts in gut microbiota, including increased abundances of beneficial genera, such as Akkermansia, Lactobacillus, and Allobaculum, and the Muribaculaceae family. PICRUSt2 functional analysis suggested an enrichment in secondary metabolite biosynthesis, vitamin (e.g., retinol) metabolism, and xenobiotic biodegradation pathways. Furthermore, BCP was associated with significantly higher levels of activated hepatic AMP-activated protein kinase (AMPK), a key energy metabolism regulator, compared to control groups. Although microbiome findings are descriptive due to the study design, these results suggest BCP as a potential dietary intervention to help mitigate age-related metabolic decline and promote healthy ageing.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press in association with The Nutrition Society

Social media summary

Our latest research presents a promising new approach to healthy aging. In a study using a premature aging mouse model, we discovered that bioactive ceramic-processed water (BCP) appears to improve both gut microbiota features and liver metabolism. Specifically, BCP promoted the growth of beneficial bacteria like Akkermansia and Allobaculum, which were linked to the activation of AMPK – a key metabolic regulator in the liver. This suggests that something as simple as drinking water can modulate the gut-liver axis to enhance metabolic health and potentially mitigate age-related diseases.

Introduction

Currently, the proportion of the older population is rapidly increasing worldwide, posing significant challenges to public health and economic systems. In this social context, efforts to understand the biological mechanisms for healthy aging are becoming essential. Healthy lifespan extension and age-related disease prevention are the crucial research priorities in a rapidly aging society. Aging is not merely the passage of time but a complex biological process influenced by various genetic and environmental factors (López-Otín et al., Reference López-Otín, Blasco, Partridge, Serrano and Kroemer2023). Expression of the senescence marker protein (SMP)30, a key aging marker, decreases with age (Fujita et al., Reference Fujita, Shirasawa, Uchida and Maruyama1996; Maruyama et al., Reference Maruyama, Ishigami and Kondo2010). Notably, this decline is mechanistically linked to several hallmarks of aging, including loss of proteostasis and mitochondrial dysfunction (López-Otín et al., Reference López-Otín, Blasco, Partridge, Serrano and Kroemer2023). Being a multifaceted protein, SMP30 is also involved in calcium homeostasis and vitC biosynthesis in most mammals, but not in humans (Drouin et al., Reference Drouin, Godin and Pagé2011).

SMP30 knockout (KO) mice, which cannot synthesize vitC, mimic human vitC deficiency and exhibit various premature aging-like phenotypes, including a shortened lifespan, increased oxidative stress, mitochondrial dysfunction, and enhanced inflammatory responses, compared to the wild-type mice (Maruyama et al., Reference Maruyama, Ishigami, Kuramoto, Handa, Kubo, Imasawa, Seyama, Shimosawa and Kasahara2004; Ishigami, Reference Ishigami2010; Park et al., Reference Park, Hong, Ki, Chung, Ishigami, Ji, Goo, Kim, Kwak, Min, Lee and Jeong2010; Saga et al., Reference Saga, Uchida, Takino, Kondo, Kobayashi, Kinoshita, Saitoh, Ishigami and Makishima2021). Crucially, SMP30’s role extends beyond vitC synthesis; its deficiency exacerbates cellular damage by disrupting calcium homeostasis, rendering hepatocytes highly susceptible to apoptosis (Ishigami et al., Reference Ishigami, Fujita, Handa, Shirasawa, Koseki, Kitamura, Enomoto, Sato, Shimosawa and Maruyama2002). Although not direct proxies of the multifactorial human aging process, these pathologies make SMP30 KO mice vital animal models to study the mechanisms underlying age-associated metabolic decline and facilitate the development of suitable interventions for chronic vitC deficiency and cellular stress. Furthermore, SMP30 KO mice exhibit prominent metabolic syndrome-like pathologies, such as impaired liver function, fatty liver, insulin resistance, and glucose metabolism disorders, suggesting that SMP30 plays an essential role in maintaining liver homeostasis (Kondo and Ishigami, Reference Kondo and Ishigami2016).

Recent studies have revealed the significant impacts of the gut microbiota on the host’s health, particularly the host’s immune function, metabolic activity, and aging process (Gao et al., Reference Gao, Xu, Liu, Liu, Bai, Peng, Li and Yin2018; Best et al., Reference Best, Dost, Esser, Flor, Gamarra, Haase, Kadibalban, Marinos, Walker, Zimmermann, Simon, Schmidt, Taubenheim, Künzel, Häsler, Franzenburg, Groth, Waschina, Rosenstiel, Sommer, Witte, Schmitt-Kopplin, Baines, Frahm and Kaleta2025). Gut microbial dysbiosis (microbial balance disruption) is closely associated with various diseases and conditions, such as obesity, diabetes, inflammatory bowel disease, neurodegenerative diseases, and accelerated ageing (Sankararaman et al., Reference Sankararaman, Noriega, Velayuthan, Sferra and Martindale2023; Nie et al., Reference Nie, You, Tang, Duan, Nepovimova, Kuca, Wu and Wei2025; Yan et al., Reference Yan, Guan, Jia, Li, Zhuoga and Zheng2025; Yu et al., Reference Yu, Ding, Wang and Jiang2025; Zhang et al., Reference Zhang, Xiang, Feng, Zhang and Xi2025). Consequently, modulation of the compositions and functions of gut microbial communities has gained attention as a novel therapeutic strategy for increased health span (Sun et al., Reference Sun, Baptista, Roberts, Jumbo-Lucioni, McMahon, Buford and Carter2020; Xiao et al., Reference Xiao, Feng, Zhao, Chen and Lu2025).

Drinking water, an essential part of daily life, continuously interacts with the gut microbial environment, with the result that its type and composition significantly influence the structures and functions of gut microbial communities (Vanhaecke et al., Reference Vanhaecke, Bretin, Poirel and Tap2022). Unlike nutritional supplements or pharmaceuticals, drinking water is the substance most easily and continuously consumed in daily life, thus holding high potential as a suitable vehicle for long-term health intervention studies. Drinking water source and solute composition have been associated with distinct gut microbiota signatures in population cohorts (Bowyer et al., Reference Bowyer, Schillereff, Jackson, Le Roy, Wells, Spector and Steves2020; Vanhaecke et al., Reference Vanhaecke, Bretin, Poirel and Tap2022). However, research focusing on the combined impact of water’s mineral profile and its unique physicochemical structure on the gut microbiome is still lacking.

This study specifically focused on investigating the impacts of bioactive ceramic-processed water (BCP), a water type derived from natural groundwater sources and subsequently treated with ceramic composed of granite and pure red clay. This specialized post-processing distinguishes BCP from conventional natural mineral water (MW, groundwater-based), intentionally positioning it as a functional water designed to induce specific biological activity. The proprietary ceramic filtration system aims to optimize the mineral profile (e.g., elevated potassium and trace elements, including barium and gallium) and cause physicochemical modification. BCP is currently a novel test substance, not widely available or commercially standardized, and not yet commercially available as a health intervention, but holds high translational potential. Previous studies (Yun et al., Reference Yun, Jeong, Do, Jeong, Jung, Park, Cho and Jeong2004; Lee et al., Reference Lee, Jeong, Noh, Jeong, DO, Kim, Kwon, Kim and Jeong2005) have suggested that these unique elemental differences confer potential hepatoprotective properties in animal models. Although human clinical data are absent due to its novel status, and its effects on human health are yet to be determined, the constituent elements of BCP are based on generally recognized safe natural minerals. Crucially, promising pre-clinical findings indicating hepatoprotective properties (Yun et al., Reference Yun, Jeong, Do, Jeong, Jung, Park, Cho and Jeong2004; Lee et al., Reference Lee, Jeong, Noh, Jeong, DO, Kim, Kwon, Kim and Jeong2005) necessitate urgent mechanistic investigation into how its distinct physicochemical properties confer biological activity. We hypothesized that these elemental differences confer a unique biological activity capable of modulating the gut environment, thereby potentially impacting host metabolism. Given that SMP30 KO mice exhibit severe age-related liver pathologies and metabolic dysfunction, BCP’s previously reported hepatoprotective potential provides a strong rationale for investigating its systemic effects, especially in the context of vitC deficiency and accelerated aging.

Considering BCP’s unique properties and the profound impact of the gut microbiota on host metabolism (particularly via the gut-liver axis), as well as the liver acting as a central metabolic hub, we explored the metabolic association between the gut and liver. Specifically, we assessed hepatic AMP-activated protein kinase (AMPK) activation, a crucial energy metabolism regulator, to clarify the potential systemic effects of BCP. The objective of this study was to evaluate the impacts of natural mineral water (MW), MW supplemented with vitC (MW-vitC), and BCP on the diversity, composition, and predicted metabolic functions of faecal microbiota in SMP30 KO mice. MW-vitC was included as a critical physiological control to dissect the effects of BCP. As vitC supplementation has been previously shown to partially mitigate some SMP30 deficiency phenotypes (Maruyama et al., Reference Maruyama, Ishigami, Kuramoto, Handa, Kubo, Imasawa, Seyama, Shimosawa and Kasahara2004), this MW-vitC control is vital to ascertain whether the observed benefits of BCP are solely due to compensating for the vitC deficiency or arise from its distinct physicochemical properties and modulation of the gut–liver axis. Furthermore, we sought to assess the distinct influence of BCP on the gut microbial ecosystem and examine its potential to mitigate age-related pathologies and improve metabolic health.

Material and methods

Animals

SMP30 KO mice were generated via gene targeting, as previously described (Ishigami et al., Reference Ishigami, Fujita, Handa, Shirasawa, Koseki, Kitamura, Enomoto, Sato, Shimosawa and Maruyama2002). The mice were housed in a room at 22 ± 3 °C under 50 ± 10% relative humidity and a 12/12-h light-dark cycle. Food and water were provided ad libitum. Body weight was measured once a week throughout the experimental period. After each 8-week period for the young group and 10-week period for the aged group drinking water regimen, the livers of mice were rapidly excised and stored at –70 °C for further analyses, including AMPK activation assessment.

Drinking water preparation

Three distinct drinking water types were used in this study: Natural MW (groundwater resources), MW-vitC (L-ascorbic acid; 1.5 g/L; Sigma), and BCP. Scheme 1 outlines the bioactive ceramic stone and BCP production process. To create bioactive ceramic stone, granite and loess powders were mixed in a 9:1 ratio, matured for 48 h, compressed at 200 °C for 30 h, and sintered at 1,050 °C for 12 h. Subsequently, BCP was produced by heating the ceramic stone with MW at 80 °C for 120 h, followed by filtration through a 0.45-μm pore-size filter.

Scheme 1. Schematics of bioactive ceramic processed water (BCP) preparation procedures. (A) Chemical compositions and mineral constituents of bioactive ceramic stone. (B) BCP manufacturing process.

Experimental design and sampling

Six- and 20-week-old male-specific pathogen-free SMP30 KO mice were divided into three experimental groups for each age cohort. Young group (six-week-old) comprised seven mice per subgroup (n = 7), whereas the aged group (20-week-old) comprised five mice per subgroup (n = 5; Figure 1). All mice were fed a vitC-free diet throughout the 8–10-week drinking water regimen. SMP30 KO mice depend on exogenous vitamin C. We therefore included MW-vitC as a physiological comparison to partially offset ascorbate deficiency, contrasted with MW and BCP. For subsequent microbiota analyses, fresh faecal samples were collected immediately before and after treatment. Individual faecal samples were collected, but for sequencing, samples were pooled within each group to generate a representative profile. The samples were placed in autoclaved Eppendorf tubes and stored at –80 °C until use.

Figure 1. Experimental design. Faecal microbiota analyses of age-specific senescence marker protein (SMP)-30 knockout (KO) mice (vitamin C-deficient) under different drinking water regimens.

DNA extraction and 16S rRNA gene sequencing

Genomic DNA was extracted from the faecal samples using the QIAamp DNA Stool Mini Kit (QIAGEN, USA), following the manufacturer’s instructions. DNA quantity was assessed using the Qubit fluorometer (Thermo-Fisher Scientific, USA), followed by storage at –20 °C. For microbiome profiling, individual faecal DNA extracts from mice within the same age × water type × timepoint cell were quantified and then normalized to 10 ng/μL. The normalized extracts were pooled at equal mass to generate one composite DNA sample per cell (Total N = 12 pooled libraries: 2 ages × 3 water types × 2 timepoints). Pooling was implemented to reduce per-sample sequencing variability and to obtain a cell-level composite profile representative of the group for descriptive comparisons. Consequently, all downstream microbiome analyses are reported as descriptive trends without group-level inferential statistics (e.g., PERMANOVA or differential abundance testing). The pooled DNA served as template to amplify the V4 hypervariable region of the 16S rRNA gene using the 515-F and 806-R primer pairs, including Illumina adapters and a unique 12-bp barcode for each sample (Caporaso et al., Reference Caporaso, Lauber, Walters, Berg-Lyons, Lozupone, Turnbaugh, Fierer and Knight2011). Sequencing was performed by Macrogen (Seoul, Korea) on the Illumina MiSeq platform (Illumina, USA), according to the manufacturer’s protocol.

Sequence processing

Sequence data were analysed using the Quantitative Insights Into Microbial Ecology 2 pipeline (Bolyen et al., Reference Bolyen, Rideout, Dillon, Bokulich, Abnet, Al-Ghalith, Alexander, Alm, Arumugam, Asnicar, Bai, Bisanz, Bittinger, Brejnrod, Brislawn, Brown, Callahan, Caraballo-Rodríguez, Chase, Cope, Da Silva, Diener, Dorrestein, Douglas, Durall, Duvallet, Edwardson, Ernst, Estaki, Fouquier, Gauglitz, Gibbons, Gibson, Gonzalez, Gorlick, Guo, Hillmann, Holmes, Holste, Huttenhower, Huttley, Janssen, Jarmusch, Jiang, Kaehler, Kang, Keefe, Keim, Kelley, Knights, Koester, Kosciolek, Kreps, Langille, Lee, Ley, Liu, Loftfield, Lozupone, Maher, Marotz, Martin, McDonald, McIver, Melnik, Metcalf, Morgan, Morton, Naimey, Navas-Molina, Nothias, Orchanian, Pearson, Peoples, Petras, Preuss, Pruesse, Rasmussen, Rivers, Robeson, Rosenthal, Segata, Shaffer, Shiffer, Sinha, Song, Spear, Swafford, Thompson, Torres, Trinh, Tripathi, Turnbaugh, Ul-Hasan, van der Hooft, Vargas, Vázquez-Baeza, Vogtmann, von Hippel, Walters, Wan, Wang, Warren, Weber, Williamson, Willis, Xu, Zaneveld, Zhang, Zhu, Knight and Caporaso2019). Demultiplexing (DADA2 pipeline), quality filtering, taxonomy assignment (Silva database version 138), and phylogenetic tree creation using the q2-phylogeny plugin with the MAFFT and FastTree2 programs were performed to sequence the reads obtained from the faecal samples. Raw sequence data have been deposited into the National Center for Biotechnology Information Sequence Read Archive (project number: PRJNA1237931).

Diversity and statistical analyses

Statistical analyses of Quantitative Insights Into Microbial Ecology 2 artifacts were conducted using the phyloseq package (v 1.50.0) in R (v.4.2.1) (McMurdie and Holmes, Reference McMurdie and Holmes2013; R Core Team, 2022). Amplicon sequence variants (ASVs) assigned to non-bacterial and unknown sequences and those with less than 10 reads per sample were excluded. To normalize the sequencing depth across all samples, the samples were rarefied to 5,000 reads.

Alpha- and beta-diversity analyses were conducted using the R packages phyloseq and vegan (McMurdie and Holmes, Reference McMurdie and Holmes2013; Oksanen et al., Reference Oksanen, Blanchet, Friendly, Kindt, Legendre, McGlinn, Minchin, Hara, Simpson, Solymos, Stevens, Szoecs and Wagner2022). Alpha diversity indices were calculated using the estimate_richness function in phyloseq. Beta diversity was evaluated using the Bray–Curtis dissimilarities (Bray and Curtis, Reference Bray and Curtis1957) and visualized via principal coordinate analysis. Due to the pooled design (n = 1 per condition), statistical hypothesis tests for diversity metrics were not performed.

Phylogenetic investigation of communities by reconstruction of unobserved states 2 (PICRUSt2) was used to predict the functions and metabolic pathways based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (Kanehisa et al., Reference Kanehisa, Sato, Kawashima, Furumichi and Tanabe2016; Yang et al., Reference Yang, Mai, Cao, Burberry, Cominelli and Zhang2023). Because the analysis unit was a pooled sample, microbiome outcomes are presented descriptively using relative abundance changes and heatmaps.

Immunoblotting analysis

Liver pieces were lysed using the radioimmunoprecipitation assay buffer containing 0.1 mM/L Na3VO4 and protease inhibitor cocktail tablets (Roche, Mannheim, Germany). The lysate was centrifuged at 14,000 rpm for 20 min at 4 °C to obtain soluble proteins. Equal quantities (40 μg) of total protein were separated via sodium dodecyl sulphate–polyacrylamide gel electrophoresis and electro-transferred to polyvinylidene difluoride membranes (Millipore Co., Billerica, MA, USA). After blocking with 3% bovine serum albumin in Tris-buffered saline containing 2% Tween-20 (TBST), the membranes were incubated with appropriate dilutions of primary antibodies in 3% bovine serum albumin in TBST. The following primary antibodies were used: Anti-phospho-AMPKα and anti-AMPKα (Cell Signalling Technology Inc., Danvers, MA, USA) antibodies. After washing thrice with TBST, the membranes were incubated with the horseradish peroxidase-conjugated secondary antibodies. Specific binding was detected using the SuperSignal West Dura Extended Duration Substrate (Pierce, Rockford, IL, USA) and developed using a medical X-ray film (Kodak, Tokyo, Japan). Images of the protein bands were scanned, and band intensities were quantified using the ImageJ software. Statistical comparisons for Western blot data (performed on individual biological replicates, n=3 per group) were conducted using one-way ANOVA followed by Tukey’s post hoc test. A p-value < 0.05 was considered statistically significant.

Results

Biometric measurements

Body weight and survival were monitored weekly throughout the experimental period (Figure 2).

Figure 2. Biometric trends and lifespan data (p > 0.05; one-way analysis of variance [ANOVA]).

Concerning body weight changes, we observed that SMP30 KO mice in young group fed MW-vitC and BCP gradually gained weight in the initial weeks (weeks 0–4), with no significant difference in early weight gain between these two groups. In contrast, the MW-treated group maintained their body weight for up to approximately week 5, after which they began to show a sharp weight loss towards the end of the experimental period. Interestingly, while the BCP-treated group also showed initial weight gain, their weight began to plateau or slightly decrease after approximately week 4, diverging from the continued steady gain observed in the MW-vitC group and showing a relatively stable, or slightly decreasing pattern of body weight towards the end of the experimental period.

As for lifespan, all mice in the MW-vitC and BCP-treated groups, across both young (6–14 weeks) and aged (20–30 weeks) subgroups, exhibited complete survival throughout the experimental period, maintaining 100% survival rate (Figure 2). However, in the MW-treated group, a decrease in survival was observed. Specifically, one mouse from the young group (initial n = 7) died naturally after 6 weeks, resulting in a survival rate of 85.7% (Figure 2). Furthermore, the aged subgroup of the MW-treated group (initial n = 5) exhibited a much lower survival rate of only 20%, indicating that four mice in this group died naturally after week 6, based on the overall observed decline in MW group survival (as detailed in the table).

This finding suggests that BCP has a positive effect on both body weight maintenance and survival rate in SMP30 KO mice. Notably, it exhibits benefits comparable to vitamin C supplementation, particularly in improving survival and mitigating the severe weight loss observed in the MW group, although the sustained weight gain seen with MW-vitC is not fully replicated.

Microbial community diversity in response to water treatment and age

Next, 16S rRNA gene sequencing of pooled 12 samples yielded 220,151 quality-filtered raw reads and 346 distinct bacterial ASVs upon further filtering and rarefaction.

Alpha diversity assessment (Figure 3A; Supplementary Table 2) suggested lower microbial species richness (observed features and ASV richness) and evenness (Shannon index) in the post-treatment groups than in the pre-treatment controls. Notably, the MW group showed the lowest species richness compared to MW-vitC and BCP treated groups. Young mice (6-week-old) consistently maintained higher ASV richness and Shannon indices than the aged mice (20-week-old). Overall composition appeared similar across water types post-treatment.

Figure 3. Faecal microbiota diversity. (A) Alpha diversity indices (observed features, Shannon, Simpson, and Pielou’s evenness indices) illustrating drinking water treatment and age-related patterns. (B) Principal coordinate analysis (PCoA) plot of Bray-Curtis dissimilarities by age and water type.

Beta diversity analysis via principal coordinate analysis based on Bray–Curtis dissimilarities (Figure 3B) revealed apparent shifts in the community structures of the groups before and after drinking water treatment. Distinct compositional differences were also observed before and after water treatment in both the young and aged mice. However, overall composition appeared similar across water type treatments (e.g., MW vs. MW-vitC vs. BCP post-treatment).

Faecal microbiota composition changes based on the drinking water type and age

Taxonomic analysis of faecal bacteria at the phylum and genus levels (Figure 4) revealed distinct shifts influenced by drinking water treatment and mouse age. Ten phyla were detected across all samples. Bacteroidota (48.53 ± 5.40%) and Firmicutes (38.61 ± 5.69%) were the most abundant, followed by Verrucomicrobiota (5.36 ± 5.36%), Campylobacterota (2.52 ± 1.28%), and Desulfobacterota (1.96 ± 1.03%; Figure 4A). Notably, Firmicutes/Bacteroidota (F/B) ratios were increased in both the young and aged mice after all drinking water treatments (Supplementary Figure 1).

Figure 4. Relative abundances of key bacterial taxa in the faecal samples. (A) Phylum-level composition showing the relative frequencies across treatment groups and time points. (B) Genus-level composition indicating the top 25 most abundant genera.

Changes in the dominant phyla, Bacteroidota and Firmicutes, differed with age. In young mice, abundances of both phyla were generally decreased after all water treatments. Specifically, the decrease in Bacteroidota abundance was more pronounced in the MW-vitC and BCP groups, with reductions of 6.70 and 9.68%, respectively, compared to the 0.96% reduction in the MW group. MW and BCP groups exhibited Firmicutes abundance reductions of 4.86 and 4.22%, respectively, whereas the MW-vitC group showed only a 0.36% reduction. Conversely, the aged group exhibited slightly elevated abundances of both Bacteroidota and Firmicutes. Although MW group showed a 1.46% decrease in Bacteroidota abundance, the MW-vitC and BCP groups showed increased abundances of 6.32 and 5.18%, respectively. Firmicutes abundance increased by 11.76 and 4.46% in the MW and BCP groups, respectively, and decreased by 1.22% in the MW-vitC group.

Verrucomicrobiota exhibited significant age-dependent changes in relative abundance. Young groups exhibited an average of 11.37 ± 4.32% increase (MW: 13.14% increase; MW-vitC: 5.42% increase; BCP: 15.56% increase), whereas the aged groups showed an average of 4.52 ± 0.60% decrease (MW: decreased by 5.04%; MW-vitC: decreased by 3.68%; BCP: decreased by 4.84%) in Verrucomicrobiota abundance after all different drinking water treatments. Unlike those of Verrucomicrobiota, response patterns of other bacterial phyla varied without a consistent trend and did not show any significant changes based on the water type and age.

Campylobacterota abundance generally decreased in both the young (by 4.08%) and aged (by 2.44%) groups after MW treatment. However, MW-vitC uniquely increased the Campylobacterota abundance in the young group (by 1.88%) and decreased it in the aged group (by 1.88%). Notably, BCP consistently reduced the Campylobacterota abundance in both the young (by 1.14%) and aged (by 2.02%) groups, suggesting a common impact across age groups. (Note: these descriptions refer to changes in the pooled population average).

Responses of Proteobacteria also varied depending on the water type and age. MW increased the Proteobacteria abundance in the aged group (by 2.84%); however, the abundance remained stable or showed minimal changes in the young group. In contrast, MW-vitC decreased the Proteobacteria abundance in the young group (by 1.28%) but increased it in the aged group (by 1.38%). Interestingly, BCP increased the Proteobacteria abundance in the young group (by 1.52%) but significantly decreased it in the aged group (by 2.20%), indicating an age-specific effect different from that observed in the other treatments.

Desulfobacterota abundance consistently decreased in both the young (by 0.52%) and aged (by 3.78%) groups following MW treatment. Deferribacteriota abundance also decreased by 1.18% in the young group and 1.88% in the aged group after MW treatment, and 1.98% in the young group after BCP treatment. Patescibacteria abundance increased only in the young MW-vit C treatment group (by 1.40%). Notably, no other detected phyla exhibited significant changes based on the drinking water type and age.

Genus-level analyses revealed significant shifts influenced by water exposure and age (Figure 4B; Table 1). Abundances of Akkermansia, Allobaculum, and Lactobacillus were markedly increased and that of Dubosiella was increased in the young mice. However, abundances of genera, such as Lachnospira, Prevotellaceae_UCG_001, and Parabacteroides, were decreased in these mice. Abundances of Allobaculum and unclassified Muribaculaceae were significantly increased, whereas those of Akkermansia, Lachnospiraceae_NK4A136, Bacteroides, Lachnospiraceae_UCG, and Helicobacter were decreased in the aged mice. Notably, Allobaculum abundance was elevated in both the young and aged mice.

Table 1. Relative abundances of the top 25 faecal microbiota genera (% of total)

Values are Δ in percentage points (pp); positive means increase, negative means decrease.

Differential effects of the drinking water type and age on the faecal microbiota

Genus-level differences in relative abundance indicated that faecal microbial communities shifted in a water regimen and age-dependent manner (Figure 5). In the young (6-week-old) group (Figure 5A), Akkermansia showed a clear positive delta across all regimens, most prominently with BCP. Allobaculum and Lactobacillus showed modest positive changes. By contrast, Lachnospiraceae_NK4A136_group exhibited the largest decreases in BCP, while several genera showed small or near-zero deltas, indicating non-uniform responses across taxa.

Figure 5. Genus-level differences in relative abundance are shown separately by young (6-week-old; A) and aged (20-week-old; B) SMP30-KO mice across drinking-water regimens. Each bar depicts the within-cell change for one pooled library; the dashed vertical line indicates no change.

In the aged (20-week-old) group (Figure 5B), patterns differed from those in the young mice. Allobaculum showed pronounced positive delta in all regimens, accompanied by increases in unclassified_Muribaculaceae, whereas Akkermansia and Bacteroides tended to show negative delta.

The genus-level heatmap likewise showed heterogeneous, regimen and age-specific changes (Supplementary Figure 2). Allobaculum retained an increase in both the young and aged groups, with varied changes depending on water type. Main differences between the age was Akkermansia, which increased in the young group with an average 11.4% and compare than pre-treatment, while decreased with 4.5% in the aged group. In contrast, unclassified_Muribaculaceae was increased in the aged group (average 8.6%) and decreased in the young group (average 1.1%) at post treatment. Collectively, these observations suggest a reorganization of the community that varies by water type and age, rather than a single directional shift affecting all taxa.

Predicted metabolic functions of the faecal microbiota

Metabolic profile of the faecal microbiota, predicted using 16S rRNA genes with the PICRUSt2 pipeline and KEGG database, revealed differential responses to drinking water type and age (Figure 6). Nine level 3 KEGG pathways were found to be differentially abundant across the groups.

Figure 6. Predicted metabolic functions of the faecal microbiota. (A) Differences in the abundances of the annotated Kyoto Encyclopaedia of Genes and Genomes (KEGG) level three pathways stratified by drinking water type and age. (B) Heatmap showing the abundances of different KEGG pathways across sample groups.

Across all groups, flagellar assembly pathway was notably enriched in the pre-treatment young mouse groups (Figure 6A). However, the phosphotransferase system was predominant in the post-treatment aged mouse groups (Figure 6A).

Critically, the most apparent changes in metabolic pathway profiles were observed in the young mice of the BCP group. These included a distinct upregulation in various secondary metabolite biosynthesis pathways (stilbenoid, diarylheptanoid, and gingerol biosynthesis), cofactor and vitamin metabolism (retinol metabolism), and xenobiotic biodegradation and metabolism pathways. Although the biosynthetic and degradative metabolism pathways appeared higher, those essential for core metabolic functions were downregulated in the MW groups. Notably, MW-vitC groups showed no clear pattern of metabolic pathway changes.

AMPK activation in response to BCP administration

We investigated the association between drinking water type and hepatic metabolism by assessing the activation of AMPK, a crucial metabolic energy regulator, in the liver.

Notably, BCP significantly increased AMPK activation in the liver tissues of the treated mice (Figure 7). Quantitative immunoblotting analysis revealed significantly higher phospho-AMPK levels than total AMPK levels in the BCP group (Figure 7A and B). This effect was statistically significant (p < 0.05) compared to the MW and MW-vitC control groups based on biological replicates (n=3).

Figure 7. Phospho- and total AMP-activated protein kinase (AMPK) levels in the liver. (A) Immunoblotting analysis of the phospho- and total AMPK levels. (B) Quantitative analysis of band intensities in (A) using the National Institutes of Health (NIH) ImageJ software. Values are expressed as the mean ± standard deviation (SD). *p < 0.05. SMP30 KO mouse experimental groups were as follows: Negative control (MW), positive control (MW-vitC), and treatment (BCP) groups.

Discussion

In this study, we used the SMP30 KO model mice to assess the mechanisms by which different drinking water types (natural MW, MW-vitC, and BCP) affect the gut microbial communities and their predicted metabolic functions. Notably, the tested water interventions consistently altered the gut microbial diversity. BCP uniquely influenced the microbial composition and metabolic pathways, causing beneficial shifts, particularly by promoting health-associated bacterial and metabolic activities. We identified a crucial link between these microbial changes and activation of hepatic AMPK, a key metabolic regulatory enzyme, providing insights into the health-promoting mechanisms of BCP.

Alpha diversity analysis (Figure 3A; Supplementary Table 2) revealed obvious reductions in microbial richness (observed features) and diversity (Shannon index) across all treatment groups, with the MW group showing the lowest diversity. vitC deficiency possibly inherently contributed to this reduction in gut microbial diversity in SMP30 KO mice, consistent with previous reports on various vitC-deficient models (Otten et al., Reference Otten, Bourgonje, Peters, Alizadeh, Dijkstra and Harmsen2021; Pham et al., Reference Pham, Dold, Rehman, Bird and Steinert2021a; Shneyderman et al., Reference Shneyderman, Kohler, Mehra, Gold, Freid and Bacharach2025). However, the less pronounced decrease in diversity in the MW-vitC and BCP groups suggests that specific components (e.g., exogenous vitC) or inherent properties (e.g., unique mineral composition or structural characteristics) of drinking water partially mitigate this reduction. This provides initial evidence of the stabilizing effects of BCP on the gut microbial environment. Despite changes in richness and Shannon diversity, Simpson’s index, and Pielou’s evenness remained consistent across treatments, indicating that, although the total number of bacterial types decreased, their relative abundances were maintained. Notably, selective enrichment of specific taxa (e.g., Akkermansia, Lactobacillus, and Allobaculum) can coincide with lower alpha diversity due to a dominance effect in compositional data (Fernandes et al., Reference Fernandes, Reid, Macklaim, McMurrough, Edgell and Gloor2014). Thus, diversity indices and taxon level changes need not move in the same direction in our dataset (Gloor et al., Reference Gloor, Macklaim, Pawlowsky-Glahn and Egozcue2017; Zmora et al., Reference Zmora, Zilberman-Schapira, Suez, Mor, Dori-Bachash, Bashiardes, Kotler, Zur, Regev-Lehavi, Brik, Federici, Cohen, Linevsky, Rothschild, Moor, Ben-Moshe, Harmelin, Itzkovitz, Maharshak, Shibolet, Shapiro, Pevsner-Fischer, Sharon, Halpern, Segal and Elinav2018; Stojanov et al., Reference Stojanov, Berlec and Štrukelj2020). Taken together, this perspective explains why water-driven increases of particular genera can coexist with reduced overall diversity. The marked increase in distance between the pre- and post-treatment samples in the beta diversity analysis (Figure 3B) clearly implied that exposure to treated water, rather than the water type itself, drives bacterial community shifts. These findings collectively suggest that even regular water consumption impacts the faecal microbiota across all ages. Age played a significant role in this study, with young mice (6-week-old) exhibiting higher ASV richness and Shannon indices than aged mice (20-week-old). This aligns with the established patterns of age-related gut microbial alterations, where diversity typically declines with age, often leading to increased dysbiosis susceptibility (Escudero-Bautista et al., Reference Escudero-Bautista, Omaña-Covarrubias, Nez-Castro, López-Pontigo, Pimentel-Pérez and Chávez-Mejía2024; Gyriki et al., Reference Gyriki, Nikolaidis, Bezirtzoglou, Voidarou, Stavropoulou and Tsigalou2025). Overall, these observations indicate a regimen- and age-dependent reorganization of the gut community rather than a uniform shift across all taxa. In particular, selective enrichment of particular genera can coincide with lower alpha diversity, so diversity indices and taxon-level changes need not move in the same direction. Our 16S rRNA sequencing analysis revealed distinct shifts in faecal bacterial composition at the phylum and genus levels influenced by both the drinking water type and mouse age (Figure 4). Bacteroidota and Firmicutes were the most abundant phyla in the samples, confirming their prominence in the healthy mammalian gut (Jandhyala et al., Reference Jandhyala, Talukdar, Subramanyam, Vuyyuru, Sasikala and Nageshwar Reddy2015; Rinninella et al., Reference Rinninella, Raoul, Cintoni, Franceschi, Miggiano, Gasbarrini and Mele2019; Koh et al., Reference Koh, Kuo, Tung, Weerawatanakorn and Pan2023). F/B ratio was increased in both the young and aged mice after drinking water treatment (Supplementary Figure 1). Elevated F/B ratio is often associated with dysbiosis in various metabolic conditions, including obesity and metabolic syndrome (Stojanov et al., Reference Stojanov, Berlec and Štrukelj2020). These associations and the inherent vitC deficiency in our SMP30 KO model suggest that interpretation of F/B ratio changes requires careful consideration and comparative analysis with normal wild-type groups for conclusive findings.

Notably, we observed age-dependent changes in the abundance of Verrucomicrobiota phylum, primarily comprising the Akkermansia genus. Verrucomicrobiota abundance was increased by an average of 11.37% in the young mice but decreased by 4.52% in the aged mice. This divergent response highlights the age-specific effects of water intervention on this phylum. Interestingly, BCP uniquely influenced the Proteobacteria responses by increasing the Proteobacteria abundance in the young group and decreasing it in the aged group (2.20%). Increased Proteobacteria abundance is often considered a signature of dysbiosis and inflammation (Litvak et al., Reference Litvak, Byndloss, Tsolis and Bäumler2017), suggesting that BCP exerts anti-inflammatory and dysbiosis-correcting effects in aged mice (Parker et al., Reference Parker, Wearsch, Veloo and Rodriguez-Palacios2020; Fu et al., Reference Fu, Li, Li, Song, Cheng, Rui and Jiang2024).

Genus-level analysis (Figure 4B; Table 1) further revealed apparent water-dependent changes with varying prevalence across age groups. Abundances of beneficial genera, such as Akkermansia, Allobaculum, and Lactobacillus, were increased in the young mice, whereas those of Allobaculum and unclassified Muribaculaceae were obviously increased in the aged mice. Interestingly, Allobaculum abundance was increased in both the young and aged mice, indicating a consistent positive outcome across all water treatment groups.

BCP notably promoted the abundance of key beneficial genera, exerting age-specific effects. Relative abundances of Akkermansia, Lactobacillus, and Allobaculum were particularly high in young mice administered BCP. Akkermansia muciniphila, a prominent member of Verrucomicrobiota, is a next-generation probiotic using mucin in the gut. It produces short-chain fatty acids (SCFAs), such as acetate and propionate, which are vital nutrients for other gut bacteria and the host (Rodrigues et al., Reference Rodrigues, Elias-Oliveira, Pereira, Pereira, Barbosa, Machado and Carlos2022; Wang et al., Reference Wang, Ma and Fu2022; Aja et al., Reference Aja, Zeng, Gray, Connelley, Chaganti and Jacobs2025; Liu et al., Reference Liu, Li, Lee, Chen and Li2025). This bacterium enhances the gut barrier function, reduces inflammation, and positively impacts various metabolic and systemic disorders, including obesity, diabetes, and neurological disorders, despite showing a tendency to decline with age (Pei et al., Reference Pei, Hu, Wang, Yang, Feng, Li, Zhang, Yan, Ju, He, Han, Yang, Xiao, Ma and Wang2023; Zeng et al., Reference Zeng, Liu, Liu, Zeng, Xie and Liu2023; Zheng et al., Reference Zheng, Han, Yuan, Xing, Zhang, Sun, Liu, Li and Mao2023; Gofron et al., Reference Gofron, Berezowski, Gofron, Borówka, Dziedzic, Kazimierczak, Kwiatkowski, Gofron, Nowaczyk and Małgorzewicz2024; Zhao et al., Reference Zhao, Yang, Wu, Yang, Xue, Xu, Zhang, Tang and Xu2024; Ma et al., Reference Ma, Liu and Yang2025). Allobaculum, a bacterium in the Firmicutes phylum, also degrades mucin, performing functions similar to A. muciniphila in maintaining the intestinal mucus layer health and producing beneficial SCFAs, such as butyrate (van Muijlwijk et al., Reference van Muijlwijk, van Mierlo, Jansen, Vermeulen, Bleumink-Pluym, Palm, van Putten and de Zoete2021; Kalkan et al., Reference Kalkan, BinMowyna, Raposo, Ahmad, Ahmed, Otayf, Carrascosa, Saraiva and Karav2025). Lactobacillus, a well-known probiotic (Firmicutes phylum), plays a crucial role in the development of early life microbial communities and the immune system via interactions with mucosal immunity and competition with pathogens (Heczko et al., Reference Heczko, Giemza, Ponikiewska and Strus2024). In the aged group administered BCP, unclassified Muribaculaceae was the next most abundant genus after Allobaculum. Muribaculaceae family (Bacteroidetes phylum) produces SCFAs primarily from endogenous (mucin glycans) and exogenous (dietary fibre) polysaccharides (Zhu et al., Reference Zhu, Chen, Zhang, Akbar, Wu, Zhang, Zhi and Shen2024) and plays a crucial role in the gut microbial ecosystem via cross-feeding relationships with other probiotics, such as Bifidobacterium and Lactobacillus (Zhu et al., Reference Zhu, Chen, Zhang, Akbar, Wu, Zhang, Zhi and Shen2024). These findings suggest that BCP fosters an environment conducive to the growth of health-promoting bacteria, thereby improving gut integrity, reducing inflammation, and enhancing overall metabolic function (Lin et al., Reference Lin, Xu, Lan, Hu, Zhang, Zhang, Lu, Sun, Yang, Liu and Xu2025).

Our observation that BCP altered gut microbial diversity and composition, with increases in genera such as Akkermansia, unclassified Muribaculaceae, and Allobaculum, is consistent with the broader notion that water characteristics can remodel gut microbial communities (Bowyer et al., Reference Bowyer, Schillereff, Jackson, Le Roy, Wells, Spector and Steves2020; Vanhaecke et al., Reference Vanhaecke, Bretin, Poirel and Tap2022). Our study specifically highlights BCP, which differs from MW not only in its processing but also in its physicochemical profile. As shown in Supplementary Table S1, BCP contains higher concentrations of potassium (K), barium (Ba), and gallium (Ga) compared to the MW control. While these trace elements remained within safe drinking water limits (e.g., Barium < 700 ppb) of the WHO guideline, it is possible that these specific elemental differences contributed to the observed biological shifts. Future studies should aim to decouple the effects of the mineral content from the structural properties of the water.

Genus-level differences indicate a regimen and age-dependent reorganization of the gut community rather than a uniform shift affecting all taxa (Figure 5, Supplementary Figure 2). Allobaculum showed a promoted increase across water regimens and age, especially MW treatment. Consistent with a previous report (Jian et al., Reference Jian, Liu, Wang, Dong and Zou2023) (Figure 4B) Akkermansia abundance notably increased in the young mice, particularly following BCP treatment, reinforcing its role as a key responder to BCP. Notably, increases in Akkermansia and Lactobacillus are often interpreted as a favourable signal for supporting gut stability, such as barrier maintenance, acidification, and cross-feeding (Plovier et al., Reference Plovier, Everard, Druart, Depommier, Van Hul, Geurts, Chilloux, Ottman, Duparc, Lichtenstein, Myridakis, Delzenne, Klievink, Bhattacharjee, van der Ark, Aalvink, Martinez, Dumas, Maiter, Loumaye, Hermans, Thissen, Belzer, de Vos and Cani2017; Gao et al., Reference Gao, Daliri, Wang, Liu, Chen, Ye and Ding2019; Rodrigues et al., Reference Rodrigues, Elias-Oliveira, Pereira, Pereira, Barbosa, Machado and Carlos2022; Heczko et al., Reference Heczko, Giemza, Ponikiewska and Strus2024; Zhu et al., Reference Zhu, Chen, Zhang, Akbar, Wu, Zhang, Zhi and Shen2024).

Metabolic profile prediction using PICRUSt2 (Figure 6) revealed functional alterations depending on the drinking water type and age. Generally, flagellar assembly pathways were enriched before water treatment in young mice, indicating high microbial motility, host adhesion, and biofilm formation, which are crucial for initial gut colonization and niche establishment (Colin et al., Reference Colin, Ni, Laganenka and Sourjik2021). Conversely, the phosphotransferase system was predominant after water treatment in aged mice, indicating enhanced sugar uptake capacity and metabolism. These findings indicated increased carbohydrate utilization flexibility in the microbial community, effectively adapting to altered nutrient availability and host health conditions (Deutscher et al., Reference Deutscher, Francke and Postma2006).

Notably, the most distinct changes in metabolic pathway profiles were observed in the young mice of the BCP group. These included the marked upregulation of various secondary metabolite biosynthesis (stilbenoid, diarylheptanoid, and gingerol biosynthesis), cofactor and vitamin metabolism (retinol metabolism), and xenobiotic biodegradation and metabolism pathways. Stilbenoids, diarylheptanoids, and gingerols are plant-derived phytoalexins exhibiting natural antioxidant, anti-inflammatory, and anti-cancer activities (He et al., Reference He, Qi, Gu, Zhang, Wang, Yang, Bi, Gong, Jiao and Xu2024; Abdullah et al., Reference Abdullah, Ahmad, Xiao, Tian, Khan, Hussain, Ahsan, Hamed, Zhong and Guan2025; Meng et al., Reference Meng, Wen, Cheng, Li, Zhang, Xiao and Xu2025). This suggests that the activated biosynthetic pathways increased the production of host health-promoting metabolites by the gut microbiota. Increased vitamin (retinol) metabolism was particularly noteworthy in vitC-deficient SMP30 KO mice. Although vitamins A and C exhibit distinct metabolic and absorption mechanisms, both are crucial for antioxidant activity, immune functions, and overall gut health (Pham et al., Reference Pham, Dold, Rehman, Bird and Steinert2021a, Reference Pham, Fehlbaum, Seifert, Richard, Bruins, Sybesma, Rehman and Steinert2021b). The observed increase in retinol metabolism, along with the known beneficial modulation of the gut microbiome by vitamin C (Pham et al., Reference Pham, Fehlbaum, Seifert, Richard, Bruins, Sybesma, Rehman and Steinert2021b), suggests plausible indirect interactions or a synergistic link between vitamins A and C, potentially mediated by the gut microbiota, which alleviates the pathologies arising from vitamin deficiency. Moreover, activation of xenobiotic biodegradation pathways by the gut microbiota has the potential to contribute to host defense against diverse foreign compounds by enhancing detoxification (Collins and Patterson, Reference Collins and Patterson2020). In contrast, although the MW groups showed the upregulation of both the biosynthetic and degradative metabolism pathways, this was accompanied by a downregulation of the pathways critical for fundamental host health and survival (e.g., core metabolic processes essential for cellular maintenance). Therefore, despite some metabolic activity enhancement, the overall beneficial impact on the host’s well-being was compromised in these groups. MW-vitC groups showed no significant metabolic pathway changes, indicating limited impact. Collectively, these distinct outcomes highlight the unique and targeted metabolic improvement effects of BCP that are particularly beneficial to mitigate age-related metabolic decline and extend far beyond simple vitC supplementation.

Liver, the central systemic energy metabolism and detoxification organ, undergoes various functional and structural changes, including increased oxidative stress, mitochondrial dysfunction, inflammation, and hepatic fibrosis, with age, all of which increase the liver disease risk (Friedman, Reference Friedman2003). AMPK is a crucial cellular energy sensor; cellular energy depletion activates AMPK to promote catabolism (energy production) and suppress anabolism (energy consumption), thereby restoring the energy balance (Shirwany and Zou, Reference Shirwany and Zou2014). In the liver, AMPK plays a complex role as a key regulator of lipid and glucose metabolism, the central component of antioxidant and anti-inflammatory defence, and a significant modulator of cell growth and survival (Jeon, Reference Jeon2016; Rey and Tamargo-Gómez, Reference Rey and Tamargo-Gómez2023). Under oxidative stress conditions, AMPK activates sirtuin 1, which stimulates the forkhead box O1 transcription factor, enhancing the mitochondrial functions and mitigating oxidative stress-induced cellular injury (Guan et al., Reference Guan, Chen and Dong2025). Therefore, AMPK functions as a core defence system counteracting age-related liver decline, maintaining energy homeostasis, and minimizing cellular damage (Salminen and Kaarniranta, Reference Salminen and Kaarniranta2012; Burkewitz et al., Reference Burkewitz, Zhang and Mair2014; Garcia and Shaw, Reference Garcia and Shaw2017). Although AMPK responsiveness to stress in the liver weakens with age, its multifaceted functions offer significant therapeutic potential in delaying the progression of various metabolic liver diseases and conditions, such as fatty liver, diabetes, obesity, liver injury, impaired regeneration, and other age-related conditions (Herzig and Shaw, Reference Herzig and Shaw2018).

After determining the positive impact of BCP on the gut microbiome, we evaluated its effects on liver tissues by assessing AMPK activation. SMP30 KO mice in BCP groups exhibited significantly higher activated AMPK levels than those in the MW and MW-vitC control groups (Figure 7). Although additional experiments are necessary to determine whether BCP can directly activate AMPK in the liver, our study suggests that it indirectly influences AMPK activation via the gut microbiome. Specifically, BCP modulates the gut microbial composition, promotes the growth of specific beneficial bacteria, and increases the production of microbial metabolites (e.g., SCFAs and secondary metabolites identified via PICRUSt2 analysis), which facilitate liver AMPK activation via the gut–liver axis (Ryu et al., Reference Ryu, Choi, Yang and Kim2020; Li et al., Reference Li, Cai, Wang, Chen, Zhang and Huang2025; Wang et al., Reference Wang, Wang, Zhuo, Chen and Chan2025). This suggests a fascinating interplay where BCP modulates the gut environment, leading to systemic metabolic benefits. BCP possibly exerts systemic effects beyond localized gut health improvement, impacting crucial organ functions, such as liver metabolism.

In this study, BCP exerted unique and beneficial effects on the gut microbiota and their metabolic functions in SMP30 KO mice, particularly young mice. Importantly, these effects were associated with increased liver AMPK activation. Our findings suggest BCP as a promising potential dietary intervention for the prevention and management of age-related metabolic diseases.

Future studies should investigate the specific active components and physical structure of BCP to elucidate the molecular mechanisms underlying its effects on gut microbiota–host interactions and AMPK activation.

Limitations

This study has several limitations that must be considered. First and foremost, to obtain sufficient DNA yield and reduce sequencing variability, faecal samples were pooled within each group (n=1 composite library per cell). This design precludes the estimation of biological variance and prevents the use of group-level inferential statistics (e.g., PERMANOVA (Anderson, Reference Anderson2001), LEfSe) for the microbiome data; thus, all microbiome findings reported here are descriptive and hypothesis-generating. Additionally, while survival trends were observed, the small sample size in the aged cohort (n=5) limits the statistical robustness of the lifespan data. Second, we did not evaluate durability after washout; health span endpoints were not included; and PICRUSt2 outputs remain predictions without metabolomic validation (e.g., SCFA quantification). Finally, we did not measure daily water intake per mouse, so we cannot rule out the possibility that palatability differences influenced the results. Future work will incorporate per-mouse sequencing, targeted metabolomics (SCFAs/retinoids), intake logging, longitudinal follow-up, and liver histology/inflammation markers.

Supplementary material

The supplementary material for this article can be found at http://doi.org/10.1017/gmb.2026.10018.

Disclosure statement

The authors declare none.

Author contribution

Conceptualization, D.H.K. and K.S.J.; Methodology, D.H.K. and S.N.C.; Formal Analysis, D.H.K.; Writing–Original Draft, S.N.C.; Writing – Review & Editing: K.A., J.H.K., K.S.K., and K.S.J.; Supervision, K.S.J.

Funding

This work was supported by the National Research Foundation of Korea (K.S.J., grant numbers GP2025-011, NRF-2017R1E1A1A01072781); the National Research Council of Science & Technology (NST) grant from the Ministry of Science and ICT (MSIT), Republic of Korea (K.S.J.); and Stellamed Co., LTD, Daegu City, Korea (K.S.J.).

Data availability statement

All data supporting the conclusions of the study are included in this article and Supplementary Material. Additional study-related data are available from the corresponding author upon reasonable request.

Ethical statement

All animal procedures adhered to the National Institutes of Health guidelines for the care and use of laboratory animals and were approved by the Animal Research and Care Committee of Kyungpook National University (permit numbers: KNU 2011-19, 2011-61, and 2014-0167).

Footnotes

D-H.K. and S-N.C. authors contributed equally to this work.

References

Abdullah, , Ahmad, N, Xiao, J, Tian, W, Khan, NU, Hussain, M, Ahsan, HM, Hamed, YS, Zhong, H and Guan, R (2025) Gingerols: Preparation, encapsulation, and bioactivities focusing gut microbiome modulation and attenuation of disease symptoms. Phytomedicine 136, 156352.Google Scholar
Aja, E, Zeng, A, Gray, W, Connelley, K, Chaganti, A and Jacobs, JP (2025) Health effects and therapeutic potential of the gut microbe Akkermansia muciniphila. Nutrients 17(3), 562.Google Scholar
Anderson, MJ (2001) A new method for non-parametric multivariate analysis of variance. Austral Ecology 26(1), 3246.Google Scholar
Best, L, Dost, T, Esser, D, Flor, S, Gamarra, AM, Haase, M, Kadibalban, AS, Marinos, G, Walker, A, Zimmermann, J, Simon, R, Schmidt, S, Taubenheim, J, Künzel, S, Häsler, R, Franzenburg, S, Groth, M, Waschina, S, Rosenstiel, P, Sommer, F, Witte, OW, Schmitt-Kopplin, P, Baines, JF, Frahm, C and Kaleta, C (2025) Metabolic modelling reveals the aging-associated decline of host-microbiome metabolic interactions in mice. Nature Microbiolgy 10(4), 973991.Google Scholar
Bolyen, E, Rideout, JR, Dillon, MR, Bokulich, NA, Abnet, CC, Al-Ghalith, GA, Alexander, H, Alm, EJ, Arumugam, M, Asnicar, F, Bai, Y, Bisanz, JE, Bittinger, K, Brejnrod, A, Brislawn, CJ, Brown, CT, Callahan, BJ, Caraballo-Rodríguez, AM, Chase, J, Cope, EK, Da Silva, R, Diener, C, Dorrestein, PC, Douglas, GM, Durall, DM, Duvallet, C, Edwardson, CF, Ernst, M, Estaki, M, Fouquier, J, Gauglitz, JM, Gibbons, SM, Gibson, DL, Gonzalez, A, Gorlick, K, Guo, J, Hillmann, B, Holmes, S, Holste, H, Huttenhower, C, Huttley, GA, Janssen, S, Jarmusch, AK, Jiang, L, Kaehler, BD, Kang, KB, Keefe, CR, Keim, P, Kelley, ST, Knights, D, Koester, I, Kosciolek, T, Kreps, J, Langille, MGI, Lee, J, Ley, R, Liu, YX, Loftfield, E, Lozupone, C, Maher, M, Marotz, C, Martin, BD, McDonald, D, McIver, LJ, Melnik, AV, Metcalf, JL, Morgan, SC, Morton, JT, Naimey, AT, Navas-Molina, JA, Nothias, LF, Orchanian, SB, Pearson, T, Peoples, SL, Petras, D, Preuss, ML, Pruesse, E, Rasmussen, LB, Rivers, A, Robeson, MS 2nd, Rosenthal, P, Segata, N, Shaffer, M, Shiffer, A, Sinha, R, Song, SJ, Spear, JR, Swafford, AD, Thompson, LR, Torres, PJ, Trinh, P, Tripathi, A, Turnbaugh, PJ, Ul-Hasan, S, van der Hooft, JJJ, Vargas, F, Vázquez-Baeza, Y, Vogtmann, E, von Hippel, M, Walters, W, Wan, Y, Wang, M, Warren, J, Weber, KC, Williamson, CHD, Willis, AD, Xu, ZZ, Zaneveld, JR, Zhang, Y, Zhu, Q, Knight, R and Caporaso, JG (2019). Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature biotechnology, 37(8), 852857.Google Scholar
Bowyer, RCE, Schillereff, DN, Jackson, MA, Le Roy, C, Wells, PM, Spector, TD and Steves, CJ (2020) Associations between UK tap water and gut microbiota composition suggest the gut microbiome as a potential mediator of health differences linked to water quality. Science of the Total Environment 739, 139697.Google Scholar
Bray, JR and Curtis, JT (1957) An ordination of the upland forest communities of Southern Wisconsin. Ecological Monographs 27(4), 325349.Google Scholar
Burkewitz, K, Zhang, Y and Mair, WB (2014) AMPK at the nexus of energetics and aging. Cell Metabolism 20(1), 1025.Google Scholar
Caporaso, JG, Lauber, CL, Walters, WA, Berg-Lyons, D, Lozupone, CA, Turnbaugh, PJ, Fierer, N and Knight, R (2011) Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proceedings of the National Academy of Sciences of the United States of America 108(Suppl 1), 45164522.Google Scholar
Colin, R, Ni, B, Laganenka, L and Sourjik, V (2021) Multiple functions of flagellar motility and chemotaxis in bacterial physiology. FEMS Microbiology Reviews 45(6), fuab038.Google Scholar
Collins, SL and Patterson, AD (2020) The gut microbiome: An orchestrator of xenobiotic metabolism. Acta Pharmaceutica Sinica B 10(1), 1932.Google Scholar
Deutscher, J, Francke, C and Postma, PW (2006) How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria [published correction appears in Microbiology and Molecular Biology Reviews 2008 Sep;72(3):555]. Microbiology and Molecular Biology Reviews 70(4), 9391031.Google Scholar
Drouin, G, Godin, JR and Pagé, B (2011) The genetics of vitamin C loss in vertebrates. Current Genomics 12(5), 371378.Google Scholar
Escudero-Bautista, S, Omaña-Covarrubias, A, Nez-Castro, AT, López-Pontigo, L, Pimentel-Pérez, M and Chávez-Mejía, A (2024) Impact of gut microbiota on aging and frailty: A narrative review of the literature. Geriatrics (Basel) 9(5), 110.Google Scholar
Fernandes, AD, Reid, JN, Macklaim, JM, McMurrough, TA, Edgell, DR and Gloor, GB (2014) Unifying the analysis of high-throughput sequencing datasets: Characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome 2, 15.Google Scholar
Friedman, SL (2003) Liver fibrosis–from bench to bedside. Journal of Hepatology 38, 3853.Google Scholar
Fu, J, Li, G, Li, X, Song, S, Cheng, L, Rui, B and Jiang, L (2024) Gut commensal Alistipes as a potential pathogenic factor in colorectal cancer. Discover Oncology 15(1), 473.Google Scholar
Fujita, T, Shirasawa, T, Uchida, K and Maruyama, N (1996) Gene regulation of senescence marker protein-30 (SMP30): Coordinated up-regulation with tissue maturation and gradual down-regulation with aging. Mechanisms of Ageing and Development 87(3), 219229.Google Scholar
Gao, Z, Daliri, EB, Wang, J, Liu, D, Chen, S, Ye, X and Ding, T (2019) Inhibitory effect of lactic acid bacteria on foodborne pathogens: A review. Journal of Food Protection 82(3), 441453.Google Scholar
Gao, J, Xu, K, Liu, H, Liu, G, Bai, M, Peng, C, Li, T and Yin, Y (2018) Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Frontiers in Cellular and Infection Microbiolgy 8, 13.Google Scholar
Garcia, D and Shaw, RJ (2017) AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance. Molecular Cell 66(6), 789800.Google Scholar
Gloor, GB, Macklaim, JM, Pawlowsky-Glahn, V and Egozcue, JJ (2017) Microbiome datasets are compositional: And this is not optional. Frontiers in Microbiology 8, 2224.Google Scholar
Gofron, K, Berezowski, A, Gofron, M, Borówka, M, Dziedzic, M, Kazimierczak, W, Kwiatkowski, M, Gofron, M, Nowaczyk, Z and Małgorzewicz, S (2024) Akkermansia muciniphila – Impact on the cardiovascular risk, the intestine inflammation and obesity. Acta Biochimica Polonica 71, 13550.Google Scholar
Guan, G, Chen, Y and Dong, Y (2025) Unraveling the AMPK-SIRT1-FOXO pathway: The in-depth analysis and breakthrough prospects of oxidative stress-induced diseases. Antioxidants (Basel) 14(1), 70.Google Scholar
Gyriki, D, Nikolaidis, CG, Bezirtzoglou, E, Voidarou, C, Stavropoulou, E and Tsigalou, C (2025) The gut microbiota and aging: Interactions, implications, and interventions. Frontiers in Aging 6, 1452917.Google Scholar
He, Y, Qi, A, Gu, Y, Zhang, C, Wang, Y, Yang, W, Bi, L, Gong, Y, Jiao, L and Xu, L (2024) Clinical efficacy and gut microbiota regulating-related effect of Si-Jun-Zi decoction in postoperative non-small cell lung cancer patients: A prospective observational study. Integrative Cancer Therapies 23, 15347354241237973.Google Scholar
Heczko, PB, Giemza, M, Ponikiewska, W and Strus, M (2024) Importance of lactobacilli for human health. Microorganisms 12(12), 2382.Google Scholar
Herzig, S and Shaw, RJ (2018) AMPK: Guardian of metabolism and mitochondrial homeostasis. Nature Reviews Molecular Cell Biology 19(2), 121135.Google Scholar
Ishigami, A (2010) Anti-aging research using SMP30/GNL knockout mice. Yakugaku Zasshi 130(1), 2528.Google Scholar
Ishigami, A, Fujita, T, Handa, S, Shirasawa, T, Koseki, H, Kitamura, T, Enomoto, N, Sato, N, Shimosawa, T and Maruyama, N (2002) Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. The American Journal of Pathology 161(4), 12731281.Google Scholar
Jandhyala, SM, Talukdar, R, Subramanyam, C, Vuyyuru, H, Sasikala, M and Nageshwar Reddy, D (2015) Role of the normal gut microbiota. World Journal of Gastroenterology 21(29), 87878803.Google Scholar
Jeon, SM (2016) Regulation and function of AMPK in physiology and diseases. Experimental & Molecular Medicine 48(7), e245.Google Scholar
Jian, H, Liu, Y, Wang, X, Dong, X and Zou, X (2023) Akkermansia muciniphila as a next-generation probiotic in modulating human metabolic homeostasis and disease progression: A role mediated by gut-liver-brain axes? International Journal of Molecular Sciences 24(4), 3900.Google Scholar
Kalkan, AE, BinMowyna, MN, Raposo, A, Ahmad, MF, Ahmed, F, Otayf, AY, Carrascosa, C, Saraiva, A and Karav, S (2025) Beyond the gut: Unveiling butyrate’s global health impact through gut health and dysbiosis-related conditions: A narrative review. Nutrients 17(8), 1305.Google Scholar
Kanehisa, M, Sato, Y, Kawashima, M, Furumichi, M and Tanabe, M (2016) KEGG as a reference resource for gene and protein annotation. Nucleic Acids Research 44(D1), D457D462.Google Scholar
Koh, YC, Kuo, LH, Tung, YC, Weerawatanakorn, M and Pan, MH (2023) Identification of indicative gut microbial guilds in a natural aging mouse model. ACS Omega 8(39), 3656936580.Google Scholar
Kondo, Y and Ishigami, A (2016) Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease. Geriatrics & Gerontology International 16(Suppl 1), 416.Google Scholar
Lee, CW, Jeong, WI, Noh, DH, Jeong, DH, DO, SH, Kim, YK, Kwon, OD, Kim, TH and Jeong, KS (2005) Protective effects of bio-active ceramic water on alcohol-induced hepatic injury in pigs. The Journal of Veterinary Medical Science 67(4), 403409.Google Scholar
Li, C, Cai, C, Wang, C, Chen, X, Zhang, B and Huang, Z (2025) Gut microbiota-mediated gut-liver axis: A breakthrough point for understanding and treating liver cancer. Clinical and Molecular Hepatology 31(2), 350381.Google Scholar
Lin, X, Xu, M, Lan, R, Hu, D, Zhang, S, Zhang, S, Lu, Y, Sun, H, Yang, J, Liu, L and Xu, J (2025) Gut commensal Alistipes shahii improves experimental colitis in mice with reduced intestinal epithelial damage and cytokine secretion. mSystems 10(3), e0160724.Google Scholar
Litvak, Y, Byndloss, MX, Tsolis, RM and Bäumler, AJ (2017) Dysbiotic proteobacteria expansion: A microbial signature of epithelial dysfunction. Current Opinion in Microbiology 39, 16.Google Scholar
Liu, Y, Li, Z, Lee, SC, Chen, S and Li, F (2025) Akkermansia muciniphila: Promises and pitfalls for next-generation beneficial microorganisms. Archives of Microbiology 207(4), 76.Google Scholar
López-Otín, C, Blasco, MA, Partridge, L, Serrano, M and Kroemer, G (2023) Hallmarks of aging: An expanding universe. Cell 186(2), 243278.Google Scholar
Ma, X, Liu, Q and Yang, G (2025) The multifaceted roles of Akkermansia muciniphila in neurological disorders. Trends in Neurosciences 48(6), 403415.Google Scholar
Maruyama, N, Ishigami, A and Kondo, Y (2010) Pathophysiological significance of senescence marker protein-30. Geriatrics & Gerontology International 10(Suppl 1), S88S98.Google Scholar
Maruyama, N, Ishigami, A, Kuramoto, M, Handa, S, Kubo, S, Imasawa, T, Seyama, K, Shimosawa, T and Kasahara, Y (2004) Senescence marker protein-30 knockout mouse as an aging model. Annals of the New York Academy of Sciences 1019, 383387.Google Scholar
McMurdie, PJ and Holmes, S (2013) Phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8(4), e61217.Google Scholar
Meng, T, Wen, Z, Cheng, X, Li, C, Zhang, P, Xiao, D and Xu, Y (2025) Unlocking gut health: The potent role of stilbenoids in intestinal homeostasis. Animals (Basel) 15(3), 417.Google Scholar
Nie, T, You, L, Tang, F, Duan, Y, Nepovimova, E, Kuca, K, Wu, Q and Wei, W (2025) Microbiota-gut-brain axis in age-related neurodegenerative diseases. Current Neuropharmacology 23(5), 524546.Google Scholar
Oksanen, J, Blanchet, FG, Friendly, M, Kindt, R, Legendre, P, McGlinn, D, Minchin, PR, O’Hara, RB, Simpson, GL, Solymos, P, Stevens, MHH, Szoecs, E and Wagner, H (2022) vegan: Community Ecology Package. R package version 2.6-4. Available at: https://CRAN.R-project.org/package=vegan.Google Scholar
Otten, AT, Bourgonje, AR, Peters, V, Alizadeh, BZ, Dijkstra, G and Harmsen, HJM (2021) Vitamin C supplementation in healthy individuals leads to shifts of bacterial populations in the gut – A pilot study. Antioxidants (Basel) 10(8), 1278.Google Scholar
Park, JK, Hong, IH, Ki, MR, Chung, HY, Ishigami, A, Ji, AR, Goo, MJ, Kim, DH, Kwak, JH, Min, CW, Lee, SS and Jeong, KS (2010) Vitamin C deficiency increases the binucleation of hepatocytes in SMP30 knock-out mice. Journal of Gastroenterology and Hepatology 25(11), 17691776.Google Scholar
Parker, BJ, Wearsch, PA, Veloo, ACM and Rodriguez-Palacios, A (2020) The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. Frontiers in Immunology 11, 906.Google Scholar
Pei, T, Hu, R, Wang, F, Yang, S, Feng, H, Li, Q, Zhang, J, Yan, S, Ju, L, He, Z, Han, Z, Yang, A, Xiao, W, Ma, Y and Wang, M (2023) Akkermansia muciniphila ameliorates chronic kidney disease interstitial fibrosis via the gut-renal axis. Microbial Pathogenesis 174, 105891.Google Scholar
Pham, VT, Dold, S, Rehman, A, Bird, JK and Steinert, RE (2021a) Vitamins, the gut microbiome and gastrointestinal health in humans. Nutrition Research 95, 3553.Google Scholar
Pham, VT, Fehlbaum, S, Seifert, N, Richard, N, Bruins, MJ, Sybesma, W, Rehman, A and Steinert, RE (2021b) Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome – A pilot study. Gut Microbes 13(1), 120.Google Scholar
Plovier, H, Everard, A, Druart, C, Depommier, C, Van Hul, M, Geurts, L, Chilloux, J, Ottman, N, Duparc, T, Lichtenstein, L, Myridakis, A, Delzenne, NM, Klievink, J, Bhattacharjee, A, van der Ark, KC, Aalvink, S, Martinez, LO, Dumas, ME, Maiter, D, Loumaye, A, Hermans, MP, Thissen, JP, Belzer, C, de Vos, WM and Cani, PD (2017) A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine 23(1), 107113.Google Scholar
R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing. Available at: https://www.R-project.org/.Google Scholar
Rey, V and Tamargo-Gómez, I (2023) From kinases to diseases: Investigating the role of AMPK in human pathologies. Kinases and Phosphatases 1(3), 181205.Google Scholar
Rinninella, E, Raoul, P, Cintoni, M, Franceschi, F, Miggiano, GAD, Gasbarrini, A and Mele, MC (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7(1), 14.Google Scholar
Rodrigues, VF, Elias-Oliveira, J, Pereira, ÍS, Pereira, JA, Barbosa, SC, Machado, MSG and Carlos, D (2022) Akkermansia muciniphila and gut immune system: A good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Frontiers in Immunology 13, 934695.Google Scholar
Ryu, JY, Choi, HM, Yang, HI and Kim, KS (2020) Dysregulated autophagy mediates sarcopenic obesity and its complications via AMPK and PGC1α signaling pathways: Potential involvement of gut dysbiosis as a pathological link. International Journal of Molecular Sciences 21(18), 6887.Google Scholar
Saga, R, Uchida, T, Takino, Y, Kondo, Y, Kobayashi, H, Kinoshita, M, Saitoh, D, Ishigami, A and Makishima, M (2021) Radiation-induced gastrointestinal syndrome is exacerbated in vitamin C-insufficient SMP30/GNL knockout mice. Nutrition 81, 110931.Google Scholar
Salminen, A and Kaarniranta, K (2012) AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Research Reviews 11(2), 230241.Google Scholar
Sankararaman, S, Noriega, K, Velayuthan, S, Sferra, T and Martindale, R (2023) Gut microbiome and its impact on obesity and obesity-related disorders. Current Gastroenterology Reports 25(2), 3144.Google Scholar
Shirwany, NA and Zou, MH (2014) AMPK: A cellular metabolic and redox sensor. A minireview. Frontiers in Bioscience - Landmark 19(3), 447474.Google Scholar
Shneyderman, M, Kohler, D, Mehra, S, Gold, S, Freid, H and Bacharach, A (2025) Exploring the role of vitamin C in gastrointestinal function and disorders. Practical Gastroenterology 21.Google Scholar
Stojanov, S, Berlec, A and Štrukelj, B (2020) The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 8(11), 1715.Google Scholar
Sun, Y, Baptista, LC, Roberts, LM, Jumbo-Lucioni, P, McMahon, LL, Buford, TW and Carter, CS (2020) The gut microbiome as a therapeutic target for cognitive impairment. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 75(7), 12421250.Google Scholar
van Muijlwijk, GH, van Mierlo, G, Jansen, PWTC, Vermeulen, M, Bleumink-Pluym, NMC, Palm, NW, van Putten, JPM and de Zoete, MR (2021) Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. Gut Microbes 13(1), 1966278.Google Scholar
Vanhaecke, T, Bretin, O, Poirel, M and Tap, J (2022) Drinking water source and intake are associated with distinct gut microbiota signatures in US and UK populations. The Journal of Nutrition 152(1), 171182.Google Scholar
Wang, N, Ma, S and Fu, L (2022) Gut microbiota feature of senile osteoporosis by shallow shotgun sequencing using aged rats model. Genes (Basel) 13(4), 619.Google Scholar
Wang, J, Wang, X, Zhuo, E, Chen, B and Chan, S (2025) Gut-liver axis in liver disease: From basic science to clinical treatment (review). Molecular Medicine Reports 31(1), 10.Google Scholar
Xiao, Y, Feng, Y, Zhao, J, Chen, W and Lu, W (2025) Achieving healthy aging through gut microbiota-directed dietary intervention: Focusing on microbial biomarkers and host mechanisms. Journal of Advanced Research 68, 179200.Google Scholar
Yan, Z, Guan, G, Jia, H, Li, H, Zhuoga, S and Zheng, S (2025) The association between gut microbiota and accelerated aging and frailty: A Mendelian randomization study. Aging Clinical and Experimental Research 37(1), 82.Google Scholar
Yang, C, Mai, J, Cao, X, Burberry, A, Cominelli, F and Zhang, L (2023) ggpicrust2: An R package for PICRUSt2 predicted functional profile analysis and visualization. Bioinformatics 39(8), btad470.Google Scholar
Yu, Y, Ding, Y, Wang, S and Jiang, L (2025) Gut microbiota dysbiosis and its impact on type 2 diabetes: From pathogenesis to therapeutic strategies. Metabolites 15(6), 397.Google Scholar
Yun, HS, Jeong, WI, Do, SH, Jeong, DH, Jung, YR, Park, JK, Cho, EM and Jeong, KS (2004) Proteome analysis by bio-active ceramic water in rat liver: Contribution to antioxidant enzyme expression, SOD I. Biochemical and Biophysical Research Communications 320(3), 852859.Google Scholar
Zeng, SY, Liu, YF, Liu, JH, Zeng, ZL, Xie, H and Liu, JH (2023) Potential effects of Akkermansia Muciniphila in aging and aging-related diseases: Current evidence and perspectives. Aging and Disease 14(6), 20152027.Google Scholar
Zhang, H, Xiang, J, Feng, J, Zhang, M and Xi, Q (2025) Gut microbiome dysbiosis and inflammatory bowel disease complement each other. Digestive Diseases 43(3), 345357.Google Scholar
Zhao, Y, Yang, H, Wu, P, Yang, S, Xue, W, Xu, B, Zhang, S, Tang, B and Xu, D (2024) Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders. Virulence 15(1), 2375555.Google Scholar
Zheng, M, Han, R, Yuan, Y, Xing, Y, Zhang, W, Sun, Z, Liu, Y, Li, J and Mao, T (2023) The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives. Frontiers in Immunology 13, 1089600.Google Scholar
Zhu, Y, Chen, B, Zhang, X, Akbar, MT, Wu, T, Zhang, Y, Zhi, L and Shen, Q (2024) Exploration of the Muribaculaceae family in the gut microbiota: Diversity, metabolism, and function. Nutrients 16(16), 2660.Google Scholar
Zmora, N, Zilberman-Schapira, G, Suez, J, Mor, U, Dori-Bachash, M, Bashiardes, S, Kotler, E, Zur, M, Regev-Lehavi, D, Brik, RB, Federici, S, Cohen, Y, Linevsky, R, Rothschild, D, Moor, AE, Ben-Moshe, S, Harmelin, A, Itzkovitz, S, Maharshak, N, Shibolet, O, Shapiro, H, Pevsner-Fischer, M, Sharon, I, Halpern, Z, Segal, E and Elinav, E (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174(6), 13881405, e21.Google Scholar
Figure 0

Scheme 1. Schematics of bioactive ceramic processed water (BCP) preparation procedures. (A) Chemical compositions and mineral constituents of bioactive ceramic stone. (B) BCP manufacturing process.

Figure 1

Figure 1. Experimental design. Faecal microbiota analyses of age-specific senescence marker protein (SMP)-30 knockout (KO) mice (vitamin C-deficient) under different drinking water regimens.

Figure 2

Figure 2. Biometric trends and lifespan data (p > 0.05; one-way analysis of variance [ANOVA]).

Figure 3

Figure 3. Faecal microbiota diversity. (A) Alpha diversity indices (observed features, Shannon, Simpson, and Pielou’s evenness indices) illustrating drinking water treatment and age-related patterns. (B) Principal coordinate analysis (PCoA) plot of Bray-Curtis dissimilarities by age and water type.

Figure 4

Figure 4. Relative abundances of key bacterial taxa in the faecal samples. (A) Phylum-level composition showing the relative frequencies across treatment groups and time points. (B) Genus-level composition indicating the top 25 most abundant genera.

Figure 5

Table 1. Relative abundances of the top 25 faecal microbiota genera (% of total)

Figure 6

Figure 5. Genus-level differences in relative abundance are shown separately by young (6-week-old; A) and aged (20-week-old; B) SMP30-KO mice across drinking-water regimens. Each bar depicts the within-cell change for one pooled library; the dashed vertical line indicates no change.

Figure 7

Figure 6. Predicted metabolic functions of the faecal microbiota. (A) Differences in the abundances of the annotated Kyoto Encyclopaedia of Genes and Genomes (KEGG) level three pathways stratified by drinking water type and age. (B) Heatmap showing the abundances of different KEGG pathways across sample groups.

Figure 8

Figure 7. Phospho- and total AMP-activated protein kinase (AMPK) levels in the liver. (A) Immunoblotting analysis of the phospho- and total AMPK levels. (B) Quantitative analysis of band intensities in (A) using the National Institutes of Health (NIH) ImageJ software. Values are expressed as the mean ± standard deviation (SD). *p < 0.05. SMP30 KO mouse experimental groups were as follows: Negative control (MW), positive control (MW-vitC), and treatment (BCP) groups.

Supplementary material: File

Kim et al. supplementary material

Kim et al. supplementary material
Download Kim et al. supplementary material(File)
File 722.2 KB